-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Health Equity Rounds Lunch

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Research, Diversity, Equity, and Inclusion (DEI), Education
Sunday, December 8, 2024: 11:30 AM-12:30 PM
Coronado Ballroom AB (Manchester Grand Hyatt San Diego)
Co-chairs:
Yvonne A. Efebera, MD, Ohio Health and Srinivas Devarakonda, MD, Ohio State University Medical Center
Disclosures:
Efebera: Oncopeptides, Sanofi, Janssen Oncology, Pfizer: Consultancy; Takeda, Oncopeptides, Alnylam, Sanofi, GlaxoSmithKline, ORCA Therapeutics, Bristol Myers Squibb/Celgene, Pharmacyclics through Alliance and AFT: Research Funding; Takeda, Janssen, Akcea Therapeutics, Alnylum: Speakers Bureau. Devarakonda: Janssen: Other: Advisory board.
Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.
Hematologic Aspects of Gender Affirming Care

Ash Blythe Alpert, MD, MFA

Yale School of Medicine, New Haven, CT
Hematologic Aspects of Gender Affirming Care

Eric Scott Mullins, MD

Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>